Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 18 and up

Using d-limonene to prevent dry mouth in head and neck cancer patients

Official title: A Phase I Study of d-Limonene With Concurrent Radiation and Platinum Based Chemotherapy for Xerostomia Prevention in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Run by Stanford University · NCT04392622 · Data updated 2026-11-12

This study is testing if taking d-limonene gelcaps can help prevent dry mouth in patients with advanced head and neck cancer who are undergoing radiation and chemotherapy.

More Xerostomia trials

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorStanford University
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Stanford, California)
StatusRecruiting
StartedFebruary 15, 2021
Main results expectedAugust 15, 2027
Study endsMay 15, 2028
Registry record updatedJuly 28, 2026
Trial IDNCT04392622 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with advanced squamous cell carcinoma of the head and neck who are scheduled to receive chemoradiation.

Probably not a fit

Patients with early-stage head and neck cancer or those not undergoing chemoradiation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the safety and maximum tolerated dose of d-limonene, a dietary supplement, when combined with radiation and platinum-based chemotherapy for patients with locally advanced head and neck squamous cell carcinoma (HNSCC). The primary objective is to assess dose-limiting toxicity, while secondary objectives include evaluating patient compliance with d-limonene administration and correlating plasma levels of the supplement with saliva flow rates and xerostomia symptoms. Participants will receive d-limonene gelcaps alongside their cancer treatment to potentially alleviate severe dry mouth caused by therapy.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of xerostomia in patients undergoing treatment for head and neck cancer.

How similar studies have gone: While the use of dietary supplements in cancer care is being explored, this specific combination of d-limonene with chemoradiation is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Histologically or cytologically confirmed diagnosis of advanced loco regional squamous cell carcinoma of the nasopharynx (AJCC v8 Stage II IV); oropharynx (AJCC v8 Stage I III for HPV+ cancer, excluding T1 2N0; AJCC v8 Stage III IV for Human papillomavirus (HPV) negative cancer); larynx (AJCC v8 Stage III to IV); or hypopharynx (AJCC v8 Stage III to IV), scheduled to undergo chemoradiation. Patients with squamous cell carcinoma of the head and neck from an unknown primary site with involved nodes (N1 to 3) also qualify.
* Scheduled to received definitive RT with concurrent platinum based chemotherapy at Stanford
* Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 to 1
* Must be able to swallow d limonene gelcaps at the time of enrollment.
* Adequate hepatic function within 2 weeks prior to registration defined as follows: Bilirubin ≤ 2 mg/dL; aspartate aminotransferase (AST) or alanine aminotransferase (ALT) \< 3 times the upper limit of normal
* Adequate hematologic function within 2 weeks prior to registration defined as follows:

  * Absolute neutrophil count (ANC): ≥ 1,500/mm3
  * Platelets: ≥ 100,000/mm3
  * Hemoglobin: ≥ 8.0 g/dL (Note: The use of transfusion or other intervention to achieve Hgb ≥ 8.0 g/dL is acceptable).
* Adequate renal function defined as follows:

Serum creatinine ≤ 1.5 mg/dL within 2 weeks prior to registration or creatinine clearance (CC) ≥ 50 mL/min within 2 weeks prior to registration determined by 24 hour collection or estimated by Cockcroft Gault formula:

CCr male = \[(140 - age) x (wt in kg)\] \[(Serum Cr mg/dL) x (72)\] CCr female = 0.85 x (CrCl male)

* Negative serum pregnancy test within 2 weeks prior to registration and agreement to use a birth control method during the entire duration of d limonene treatment for women of childbearing potential
* Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

* History of allergic reactions attributed to citrus fruits
* Pregnant or lactating

Where it's running

  • Stanford University
    Stanford, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Foot reflexology and ta-VNS for symptom relief in head and neck cancer during CCRT

    This trial tests whether foot reflexology, transcutaneous auricular vagus nerve stimulation, and auricular acupressure can reduce pain, dry mouth, fatigue, and other symptoms for head and neck cancer patients receiving cisplatin-based chemoradiotherapy.

    Recruiting Tzu Chi University · Hualien City · NCT07711626

  • Does Hyaluronic Acid Help Dry Mouth?

    This study tests whether injecting hyaluronic acid under the lining of the mouth can relieve dry mouth in adults with xerostomia, compared to a placebo.

    Recruiting University of Barcelona · Barcelona, Barcelona · NCT07594184

  • Oral7 Mouth Spray for dry mouth in older adults

    This test checks if Oral7 mouth spray can ease dry mouth and improve saliva flow and quality of life in people aged 60 and up with xerostomia.

    Recruiting Mbd Marketing Sdn. Bhd. · Kubang Kerian, Kelantan · NCT06984848

  • Acupressure for dry mouth in head and neck cancer patients

    This study is testing if self-applied acupressure can help reduce dry mouth symptoms in people with head and neck cancer compared to just receiving oral health education.

    Recruiting The University of Hong Kong · Hong Kong, Hong Kong · NCT06465628

  • Injecting bone marrow cells to treat dry mouth

    This study is testing if injecting special cells from bone marrow into the salivary glands can help people with dry mouth caused by conditions like Sjögren's disease feel better.

    Recruiting Phase 1 University of Wisconsin, Madison · Madison, Wisconsin · NCT06392711

  • Using light therapy and mobile health to improve quality of life in head and neck cancer patients

    This study is testing whether light therapy can help improve the quality of life and oral health for people who have survived head and neck cancer and are dealing with dry mouth from radiation treatment.

    Recruiting Universidad de Granada · Granada · NCT05106608

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.